卫生技术评估中贴现率的理论进展与实践探索  

An Overview of the Theory and Practice of Discounting in Health Technology Assessment

作　　者：陶田甜 田晨惠 马瑞 陈平钰 Tao Tiantian;Tian Chenhui;Ma Rui;Chen Pingyu(School of Pharmacy,Nanjing Medical University,Nanjing,211166,China)

机构地区：[1]南京医科大学药学院,南京211166 [2]中国药科大学,南京211198

出　　处：《中国卫生经济》2024年第5期92-96,共5页Chinese Health Economics

摘　　要：目的:文章旨在探讨卫生技术评估中的贴现率设定问题,为完善我国贴现率的制定提供参考。方法:文章以文献综述和经验案例为基础,通过比较分析英国和加拿大的实践经验,分析药物经济学评价和各国指南中的贴现率设定依据。结果:社会时间偏好法和社会机会成本法为贴现率的测算提供了研究视角,但在国际指南和药经评价实践中对贴现率的选择存在差异,可能反映了各国在经济环境、医疗体系和价值观念等方面的不同。结论:文章呼吁开展贴现设定相关基础研究,并建议制定符合我国经济环境的贴现率,为决策者提供可靠的信息基础。Objective:It explores critical issues of discounting in health technology assessment to provide a reference for improving discount rates in China.Methods:Based on literature review and empirical cases,it compares and analyzes the practical experience of the UK and Canada and the basis for discount rate setting in pharmacoeconomic evaluation and guidelines of various countries.Results:It is found that the social time preference and social opportunity cost approach provide research perspectives for discount rate calculation.However,there are differences in the choice of discounting in international guidelines and pharmacoeconomic evaluation practices,which may reflect differences among countries regarding economic environment,healthcare systems,and values.Conclusion:It calls for more basic research on discounting and suggests the formulation of discount rates that align with our China's economic environment to provide decision-makers with a reliable information foundation.

关 键 词：贴现率 卫生技术评估 社会时间偏好 社会机会成本 

分 类 号：R1-9[医药卫生—公共卫生与预防医学] R197.1